Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Evaluation of AboutFace: Novel Peer Education Resource for Veterans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02486692
Recruitment Status : Completed
First Posted : July 1, 2015
Results First Posted : May 6, 2019
Last Update Posted : June 5, 2019
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development

Brief Summary:
The purpose of this study is to evaluate the AboutFace peer education website for the purpose of reducing stigma and improving attitudes toward seeking mental health services among Veterans.

Condition or disease Intervention/treatment Phase
PTSD Other: AboutFace Website Not Applicable

Detailed Description:
Research suggests that at least 1 in 10 Veterans will meet criteria for posttraumatic stress disorder (PTSD) related to their military experience. Treatment is widely available to Veterans with PTSD, and national dissemination initiatives have increased Veterans' access to best practice interventions. However, treatment seeking remains strikingly low among Veterans with PTSD. In fact, most Veterans with PTSD do not seek mental health services due to perceived stigma and other associated barriers. The National Center for PTSD recently developed and launched AboutFace, a peer education resource for Veterans. The investigators of this study believe that AboutFace has tremendous potential to reduce stigma and improve attitudes toward seeking mental health services among Veterans. However, it has not yet been evaluated. Investigators have partnered with the National Center for PTSD to launch this mixed methods pilot evaluation of AboutFace. There will be two phases to this study. During Phase I- Usability, 20 Veterans will be recruited to participate in individual interviews during which they will be asked to describe the ease of use of the AboutFace website for the researchers. During Phase II- Feasibility, 60 Veterans will be randomized to one of two conditions- About Face or Usual Care. All participants will complete several brief assessments measuring PTSD symptoms and attitudes toward seeking mental health services. Participants will then be randomized to either receive a link to the About Face website or to receive a link to a general online brochure about PTSD. After two weeks, participants will complete the assessment measures once again to determine any changes in attitudes toward seeking mental health services and potential changes in PTSD symptoms.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Pilot Evaluation of AboutFace: A Novel Peer Education Resource for Veterans
Study Start Date : April 2015
Actual Primary Completion Date : September 2016
Actual Study Completion Date : December 2016

Arm Intervention/treatment
Experimental: Phase II- Experimental Group
Participants were provided with instructions and a web link for accessing the AboutFace website after the baseline assessment.
Other: AboutFace Website
AboutFace is an informational website that utilizes digital storytelling to describe PTSD symptoms and different treatments for PTSD.

No Intervention: Phase II- Usual Care Group
Participants were provided with instructions and a web link for accessing some online PTSD education materials after the baseline assessment.



Primary Outcome Measures :
  1. Endorsed and Anticipated Stigma Inventory (EASI) [ Time Frame: pre-treatment (baseline) & post-treatment (two-week) assessment ]

    THE EASI assesses for perceptions of treatment effectiveness, stigma, and external barriers to treatment seeking. Answers are ranked from 1 to 5 with 1 being "Strongly Disagree" and 5 being "Strongly Agree" and higher scores are indicative of greater stigma. Total scores can range from 40 to 190.

    Phase I participants did not participate in Phase II (the clinical trial portion of the study) and were not assessed using this measure.


  2. PTSD Checklist (PCL-V) [ Time Frame: pre-treatment (baseline) & post-treatment (2-week) assessment ]

    The PCL-V is a 20-item self-report measure that assesses PTSD severity. Individual item responses can range from 0-4 with 0 being "Not At All" and 4 being "Extremely" and total scores can range from 0 to 80. Higher numbers on the PCL-V are indicative of greater PTSD severity.

    Phase I participants did not participate in Phase II (the clinical trial portion of the study) and were not assessed using this measure.


  3. PTSD Treatment Initiators [ Time Frame: two weeks post assessment ]
    percentage/rate of PTSD treatment initiation at post assessment (2-weeks) Phase I participants did not participate in Phase II (the clinical trial portion of the study) and were not assessed using this measure.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Must be 18 years of age
  • Recommended for PTSD treatment following evaluation
  • Internet access
  • English Speaking

Exclusion Criteria:

  • Minors under the age of 18
  • Non-Veterans
  • Negative for PTSD

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02486692


Locations
Layout table for location information
United States, South Carolina
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States, 29401-5799
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Layout table for investigator information
Principal Investigator: Kenneth J Ruggiero, PhD MA BA Ralph H. Johnson VA Medical Center, Charleston, SC
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT02486692    
Other Study ID Numbers: PPO 14-360
First Posted: July 1, 2015    Key Record Dates
Results First Posted: May 6, 2019
Last Update Posted: June 5, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by VA Office of Research and Development:
Mental Health
PTSD
Stigma
Peer Education
Web Education
Self Help